Viewing Study NCT03562195


Ignite Creation Date: 2025-12-24 @ 2:01 PM
Ignite Modification Date: 2026-02-21 @ 7:52 PM
Study NCT ID: NCT03562195
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2018-05-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 201536
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators